Going Concern (new) — Management disclosed substantial doubt about ability to continue as going concern due to liquidity constraints and business combination deadline.
Material Weakness (worsened) — Material weakness continues into second year with identical description, indicating no remediation progress.

NASDAQ: RIBBR Ribbon Acquisition Corp. 10-K

Ribbon signs DRC Medicine merger, faces going concern warning as 29% of shares redeem

Filed March 31, 2026 · Period ending December 31, 2025 · Compared to 10-K Apr 1, 2025 · ~1 min read

Key Changes

high

Company entered definitive merger agreement with DRC Medicine on June 30, 2025, ending target search and focusing solely on closing this transaction. Shareholders approved deadline extension in January 2026 to allow more time to complete the deal.

Business: Business Combination Agreement verify on EDGAR →
high

Management disclosed substantial doubt about ability to continue as going concern due to liquidity constraints and business combination deadline pressure. Working capital swung from positive $494K to negative $556K deficit.

MD&A: Going Concern verify on EDGAR →
high

1.44 million shares (29% of IPO) redeemed in January 2026 for $14.9 million at $10.40/share, reducing trust account capital available to fund the DRC Medicine transaction and future operations.

MD&A: Shareholder Redemptions verify on EDGAR →

2 more material changes plus the full narrative summary — create a free account to see the rest. Takes 30 seconds.

Partner

Trade RIBBR commission-free

Open an account, get a free stock.

Investing involves risk. Free stock terms apply.

Generated by AI · Jun 8, 2026 6:19 PM